"Propanolamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.
| Descriptor ID |
D011412
|
| MeSH Number(s) |
D02.033.100.624 D02.033.755.624 D02.092.063.624
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propanolamines".
Below are MeSH descriptors whose meaning is more specific than "Propanolamines".
This graph shows the total number of publications written about "Propanolamines" by people in this website by year, and whether "Propanolamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propanolamines" by people in Profiles.
-
Carmody K, Asaly M, Blackstock U. Point of Care Echocardiography in an Acute Thoracic Dissection?with Tamponade in a Young Man with Chest Pain, Tachycardia, and Fever. J Emerg Med. 2016 Nov; 51(5):e123-e126.
-
Carr R, Schilling J, Song J, Carter RL, Du Y, Yoo SM, Traynham CJ, Koch WJ, Cheung JY, Tilley DG, Benovic JL. ?-arrestin-biased signaling through the ?2-adrenergic receptor promotes cardiomyocyte contraction. Proc Natl Acad Sci U S A. 2016 07 12; 113(28):E4107-16.
-
O-Uchi J, Komukai K, Kusakari Y, Morimoto S, Kawai M, Jhun BS, Hurst S, Hongo K, Sheu SS, Kurihara S. Alpha1-adrenenoceptor stimulation inhibits cardiac excitation-contraction coupling through tyrosine phosphorylation of beta1-adrenoceptor. Biochem Biophys Res Commun. 2013 Apr 05; 433(2):188-93.
-
O-Uchi J, Lopes CM. Combined blockade of ?- and a1-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not? Hypertens Res. 2010 Oct; 33(10):984-5.
-
Kowey PR. A review of carvedilol arrhythmia data in clinical trials. J Cardiovasc Pharmacol Ther. 2005 Jun; 10 Suppl 1:S59-68.
-
Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL, Barone FC. Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats. J Pharmacol Exp Ther. 2001 Sep; 298(3):879-85.
-
Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR, Ohlstein EH, Ma XL, Yue TL. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Eur J Pharmacol. 2000 Oct 06; 406(1):109-16.
-
Christopher TA, Lopez BL, Ma XL, Feuerstein GZ, Ruffolo RR, Yue TL. Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injury. Br J Pharmacol. 1998 Jan; 123(2):292-8.
-
Chen L, Ma L, de Prada VA, Chen M, Feng YJ, Waters D, Gillam L, Chen C. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography. J Am Coll Cardiol. 1996 Dec; 28(7):1866-76.
-
Ma XL, Yue TL, Lopez BL, Barone FC, Christopher TA, Ruffolo RR, Feuerstein GZ. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. J Pharmacol Exp Ther. 1996 Apr; 277(1):128-36.